Drug Companies Threatening to Oppose Health Bill

The drug industry is threatening to end its support for President Barack Obama's health overhaul effort because of a rift with the administration over protecting brand-name biotech drugs from low-cost generic competitors.
In an e-mail obtained Friday by The Associated Press, the president of the Pharmaceutical Research and Manufacturers of America told the trade group's board members that "we could not support the bill" if the industry is given less ... Full Story »

Posted by Patricia Blochowiak

See All Reviews »

Review

Richard Riehl
3.0
by Richard Riehl - Jan. 19, 2010

A basic overview of why the drug companies are having second thoughts, but the article lacks sourcing from experts to show whether PhRMA has a legitimate case. Without expert analysis, the story amounts to little more than "they said," "they said."

See All Reviews »

Richard's Rating

Overall
3.0

Average
from 19 answers
Quality
2.9
Facts
4.0
Fairness
4.0
Information
3.0
Insight
3.0
Sourcing
3.0
Style
3.0
Accuracy
3.0
Balance
4.0
Context
2.0
Depth
2.0
Enterprise
2.0
Expertise
1.0
Originality
2.0
Relevance
5.0
Transparency
3.0
Responsibility
3.0
Popularity
3.0
Recommendation
3.0
Credibility
3.0
More How our ratings work »